Article

Metabolic Reprogramming：Application of lipid metabolism related genes in the risk model of clinical prognosis of pancreatic cancer

2023-12-20

Abstract excerpt

Pancreatic cancer(PC) is a highly invasive digestive system tumor, with a 5-year survival rate of less than 10%. However, the mechanism of its occurrence remains unclear. Metabolic alterations in malignant tumor cells have been found to occur throughout the processes of uptake, synthesis, and degradation, making metabolic reprogramming one of the characteristics of malignant tumors. Disturbances in lipid metabolis...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 5e4310c6-ccb0-54d5-b1ed-1e5952b2744f
DOI: 10.21203/rs.3.rs-3744911/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Metabolic Reprogramming：Application of lipid metabolism related genes in the risk model of clinical prognosis of pancreatic cancerDOI 10.21203/rs.3.rs-3744911/v1Read

Novel strategy for oncogenic alteration-induced lipid metabolism reprogramming in pancreatic cancer.Semantic proximity Read

Metabolic Syndrome Related Gene Signature Predicts the Prognosis of Patients With Pancreatic Ductal Carcinoma. A Novel Link Between Metabolic Dysregulation and Pancreatic Ductal Carcinoma.Semantic proximity Read

Genomic analysis and filtration of novel prognostic biomarkers based on metabolic and immune subtypes in pancreatic cancerSemantic proximity Read

A metabolism-relevant signature as a predictor for prognosis and therapeutic response in pancreatic cancer.Semantic proximity Read

PLPP2 as a metabolic and immune marker for predicting survival and enhancing response to anti-PD1 therapy in pancreatic cancerSemantic proximity Read

Metabolic reprogramming shapes the immune microenvironment in pancreatic adenocarcinoma: prognostic implications and therapeutic targetsSemantic proximity Read

PTGES Expression Is Associated with Metabolic and Immune Reprogramming in Pancreatic Ductal AdenocarcinomaSemantic proximity Read

Plasma Metabolome Profiling Identifies Metabolic Subtypes of Pancreatic Ductal AdenocarcinomaSemantic proximity Read

The value of a metabolic reprogramming-related gene signature for pancreatic adenocarcinoma prognosis predictionSemantic proximity Read

The biological role of metabolic reprogramming in pancreatic cancerSemantic proximity Read

Development of a KRAS-Associated Metabolic Risk Model for Prognostic Prediction in Pancreatic Cancer.Semantic proximity Read

Molecular characterization of metabolic subtypes of gastric cancer based on metabolism-related lncRNASemantic proximity Read